Park, Won <br/><br/>
A randomised, double-blind, multicentre, parallel-group, prospective study comparing the pharmacokinetics, safety, and efficacy of CT-P13 and innovator infliximab in patients with ankylosing spondylitis: the PLANETAS study.  [electronic resource] 

 -  Annals of the rheumatic diseases  Oct 2013 
 - 1605-12 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1468-2060 
<br/><br/><label>Standard No.: </label>10.1136/annrheumdis-2012-203091  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antibodies, Monoclonal--adverse effects<br/>Antibody Formation<br/>Antirheumatic Agents--adverse effects<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Immunoglobulin G--adverse effects<br/>Infliximab<br/>Male<br/>Middle Aged<br/>Prospective Studies<br/>Severity of Illness Index<br/>Spondylitis, Ankylosing--blood<br/>Treatment Outcome<br/>Young Adult